Results summary | View all lists in GO:BiolProc | View all genes in L01D.profile.u50 |
List Name | Description | Total probes |
Expected matches |
Actual matches |
Fold Enrichment |
Binomial p-value |
---|---|---|---|---|---|---|
muscle contraction | A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. | 246 | 0.61 | 5 | 8.22 | 4.06e-04 |
protein secretion | The regulated release of proteins from a cell or group of cells. | 66 | 0.16 | 3 | 18.39 | 6.15e-04 |
glycolysis | The chemical reactions and pathways resulting in the breakdown of a monosaccharide (generally glucose) into pyruvate, with the concomitant production of a small amount of ATP. Pyruvate may be converted to ethanol, lactate, or other small molecules, or fed into the TCA cycle. | 69 | 0.17 | 3 | 17.59 | 7.01e-04 |
transcription from RNA polymerase I promoter | The synthesis of RNA from a DNA template by RNA polymerase I (Pol I), originating at a Pol I-specific promoter. | 17 | 0.04 | 2 | 47.59 | 8.11e-04 |
fructose metabolic process | The chemical reactions and pathways involving fructose, the ketohexose arabino-2-hexulose. Fructose exists in a open chain form or as a ring compound. D-fructose is the sweetest of the sugars and is found free in a large number of fruits and honey. | 20 | 0.05 | 2 | 40.45 | 1.13e-03 |
secretion | The regulated release of a substance by a cell, a group of cells, or a tissue. | 465 | 1.15 | 6 | 5.22 | 1.18e-03 |
glucose catabolic process | The chemical reactions and pathways resulting in the breakdown of glucose, the aldohexose gluco-hexose. | 86 | 0.21 | 3 | 14.11 | 1.33e-03 |
hexose catabolic process | The chemical reactions and pathways resulting in the breakdown of hexose, any aldose with a chain of six carbon atoms in the molecule. | 103 | 0.25 | 3 | 11.78 | 2.22e-03 |
monosaccharide catabolic process | The chemical reactions and pathways resulting in the breakdown of monosaccharides, polyhydric alcohols containing either an aldehyde or a keto group and between three to ten or more carbon atoms. | 103 | 0.25 | 3 | 11.78 | 2.22e-03 |
cellular protein complex disassembly | The disaggregation of a protein complex into its constituent components, occurring at the level of an individual cell. Protein complexes may have other associated non-protein prosthetic groups, such as nucleic acids, metal ions or carbohydrate groups. | 29 | 0.07 | 2 | 27.90 | 2.37e-03 |
alcohol catabolic process | The chemical reactions and pathways resulting in the breakdown of alcohols, any of a class of alkyl compounds containing a hydroxyl group. | 106 | 0.26 | 3 | 11.45 | 2.41e-03 |
macromolecular complex disassembly | The disaggregation of a macromolecular complex into its constituent components. | 30 | 0.07 | 2 | 26.97 | 2.54e-03 |
protein complex disassembly | The disaggregation of a protein complex into its constituent components. Protein complexes may have other associated non-protein prosthetic groups, such as nucleic acids, metal ions or carbohydrate groups. | 30 | 0.07 | 2 | 26.97 | 2.54e-03 |
fatty acid metabolic process | The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis. | 234 | 0.58 | 4 | 6.92 | 2.90e-03 |
female pregnancy | The physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. | 118 | 0.29 | 3 | 10.28 | 3.26e-03 |
G-protein signaling, coupled to cAMP nucleotide second messenger | The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, followed by modulation of adenylyl cyclase activity and a subsequent change in the concentration of cyclic AMP. | 125 | 0.31 | 3 | 9.71 | 3.83e-03 |
post-Golgi vesicle-mediated transport | The directed movement of substances from the Golgi to other parts of the cell, including organelles and the plasma membrane, mediated by small transport vesicles. | 39 | 0.10 | 2 | 20.75 | 4.26e-03 |
cellular carbohydrate catabolic process | The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells. | 130 | 0.32 | 3 | 9.34 | 4.28e-03 |
carbohydrate catabolic process | The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. | 132 | 0.33 | 3 | 9.19 | 4.46e-03 |
cAMP-mediated signaling | A series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response. | 134 | 0.33 | 3 | 9.06 | 4.65e-03 |
adenylate cyclase activation | Any process that initiates the activity of the inactive enzyme adenylate cyclase. | 46 | 0.11 | 2 | 17.59 | 5.88e-03 |
generation of precursor metabolites and energy | The chemical reactions and pathways resulting in the formation of precursor metabolites, substances from which energy is derived, and the processes involved in the liberation of energy from these substances. | 646 | 1.60 | 6 | 3.76 | 5.91e-03 |
glucose metabolic process | The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. | 150 | 0.37 | 3 | 8.09 | 6.36e-03 |
positive regulation of cyclase activity | Any process that activates or increases the activity of a cyclase. | 48 | 0.12 | 2 | 16.86 | 6.39e-03 |
positive regulation of adenylate cyclase activity | Any process that activates or increases the frequency, rate or extent of adenylate cyclase activity. | 48 | 0.12 | 2 | 16.86 | 6.39e-03 |
positive regulation of lyase activity | Any process that activates or increases the frequency, rate or extent of lyase activity, the catalysis of the cleavage of C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond. | 48 | 0.12 | 2 | 16.86 | 6.39e-03 |
carboxylic acid metabolic process | The chemical reactions and pathways involving carboxylic acids, any organic acid containing one or more carboxyl (COOH) groups or anions (COO-). | 679 | 1.68 | 6 | 3.57 | 7.46e-03 |
cellular component disassembly | A cellular process that results in the breakdown of a part of the cell. | 52 | 0.13 | 2 | 15.56 | 7.46e-03 |
monocarboxylic acid metabolic process | The chemical reactions and pathways involving monocarboxylic acids, any organic acid containing one carboxyl (COOH) group or anion (COO-). | 307 | 0.76 | 4 | 5.27 | 7.50e-03 |
organic acid metabolic process | The chemical reactions and pathways involving organic acids, any acidic compound containing carbon in covalent linkage. | 681 | 1.68 | 6 | 3.56 | 7.56e-03 |
striated muscle contraction | A process leading to shortening and/or development of tension in striated muscle tissue. | 54 | 0.13 | 2 | 14.98 | 8.03e-03 |
response to drug | A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. | 57 | 0.14 | 2 | 14.19 | 8.91e-03 |
G-protein signaling, coupled to cyclic nucleotide second messenger | The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, followed by modulation of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide. | 171 | 0.42 | 3 | 7.10 | 9.09e-03 |
G-protein signaling, adenylate cyclase activating pathway | The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, followed by activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP. | 58 | 0.14 | 2 | 13.95 | 9.21e-03 |